Indivior Pharmaceuticals Net Profit Margin Growth & History (INDV)
Indivior Pharmaceuticals's net profit margin was 16.95% for fiscal 2025.
View full Indivior Pharmaceuticals company overviewIndivior Pharmaceuticals annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | 16.95% | +16.36 pp |
| 2024 | 2024-12-31 | 0.59% | +12.12 pp |
| 2023 | 2023-12-31 | −11.53% | −6.64 pp |
| 2022 | 2022-12-31 | −4.88% | −30.80 pp |
| 2021 | 2021-12-31 | 25.92% | — |
Indivior Pharmaceuticals quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | 35.57% | +29.61 pp |
| Q1 2026 | 2026-03-31 | 28.08% | +10.41 pp |
| Q4 2025 | 2025-12-31 | 28.85% | +21.80 pp |
| Q3 2025 | 2025-09-30 | 13.38% | +6.21 pp |
| Q2 2025 | 2025-06-30 | 5.96% | +38.40 pp |
| Q1 2025 | 2025-03-31 | 17.67% | −3.81 pp |
| Q4 2024 | 2024-12-31 | 7.05% | — |
| Q3 2024 | 2024-09-30 | 7.17% | — |
| Q2 2024 | 2024-06-30 | −32.44% | — |
| Q1 2024 | 2024-03-31 | 21.48% | — |
Indivior Pharmaceuticals net profit margin trends
Between the periods ended 2021-12-31 and 2025-12-31, Indivior Pharmaceuticals's net profit margin decreased from 25.92% to 16.95%, a change of −8.97 percentage points. The latest reported quarter, Q2 2026, shows 35.57%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Indivior Pharmaceuticals source filings ↗